Paritaprevir dihydrate
Paritaprevir dihydrate (ABT-450) is a potent, orally bioavailable NS3/4A protease inhibitor effective against HCV genotypes 1a/1b and a SARS-CoV 3CLpro inhibitor. Its pharmacokinetics are enhanced by co-administration with Ritonavir. This compound is a key research tool for antiviral studies in both biochemical and cellular assay systems.
Product Specifications
CAS Number
1456607-71-8
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Smiles
O.O.Cc1cnc (cn1) C (=O) N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2 (NC (=O) [C@@H]2C[C@H] (CN2C1=O) Oc1nc2ccccc2c2ccccc12) C (=O) NS (=O) (=O) C1CC1
Molecular Formula
C40H47N7O9S
Molecular Weight
801.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV740431 1.0 µg DNA
PIRC17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 
LS003309-20ug 20 µg
GRP78 (HSPA5) (NM_005347) Human Over-expression Lysate
Sign In for Pricing
View Details